Picture of VivoSim Labs logo

VIVS — VivoSim Labs News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Organovo posts Q3 loss per share $0.09

Nov 9 (Reuters) - Organovo Holdings Inc  ONVO.O  
    * Organovo announces fiscal second-quarter 2018 results; 
company 
shifts commercial focus to higher-value disease modeling 
opportunities and updates full-year fiscal 2018 outlook 
    * Q2 loss per share $0.09 
    * Q2 revenue $1.4 million versus I/B/E/S view $1.4 million 
    * Sees FY 2018 revenue $4.5 million to $6.5 million 
    * Q2 earnings per share view $-0.10 -- Thomson Reuters 
I/B/E/S 
 
Source text for Eikon:  ID:nGNXOGUQVa  
Further company coverage:  ONVO.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))

Recent news on VivoSim Labs

See all news